Versions Compared

Old Version 27

changes.mady.by.user Lydia Foeken

Saved on

compared with

New Version 28

changes.mady.by.user Lydia Foeken

Saved on

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

...

WMDA StandardTitle and link to documentExplanationStatus

9.02

Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT).

Global consensus document to perform long-term follow up on donors till 10 years after donation.Current (2017)

3.22

3.22.3

Suitability Criteria for Adult Related Donors: A Consensus Statement from the Worldwide Network for Blood and Marrow Transplantation Standing Committee on Donor Issues.

Biology of Blood and Marrow Transplantation (2015) 21: 2052-2060		Global consensus document with recommendations for donor workup and final clearance of family donors who would not be able to serve as unrelated donors because of their age or pre-existing diseases. This article covers different topics intending to support decision-making, with the goal of minimizing medical risk to the donor and protection of the recipient from transmissible diseases.Current (2017)



Archived Publications

WMDA StandardTitle and link to documentExplanationStatus

3.04, 3.05, 3.06, 3.09, 3.10.1, 3.11, 3.11.1, 3.13, 3.15

Informed consent--suggested procedures for informed consent for unrelated haematopoietic stem cell donors at various stages of recruitment, donor evaluation, and donor workup.

Bone Marrow Transplantation (2003) 31: 539-545

This is a checklist to set up an informed consent at the various stages. The paper has been replaced by the WMDA Guidance to explain the WMDA Standards. The guidance can be found at: https://share.wmda.info/x/0wB7CwOut of date


Standards, regulations  and accreditation for registries involved in the worldwide exchange of hematopoietic stem cell donors and products.

Bone Marrow Transplantation (2010), 45:819-824

WMDA has developed online documentation to explain the accreditation process, which is available at WMDA Share under the pillar: 'Ensuring Quality'Out of date

International exchange of cord blood units; the registry aspects

Bone Marrow Transplantation (2010), 45: 825-831

Replaced by chapter 6 of the WMDA handbook: a gift of lifeOut of date
8.05

Concerns about the use of biosimilar granulocyte colony-stimulating factors for the mobilisation of stem cells in normal donors: position of World Marrow Donor Association.

Haematologica (2011): 96:942-943

The aim of this paper is to review the basis of regulatory approval of the biosimilar G-CSF agents, including the available safety data, with reference to the indication for mobilization of PBSC in normal donors and to make recommendations based on these.

The recommendation has been updated in 2017.

Out of date

3.22

3.22.2

Haematopoietic stem cell donor registries: World Marrow Donor Association recommendations for evaluation of donor health.

Bone Marrow Transplantation (2008) 42: 9-14

This document describes criteria for permanent or temporary deferral, guidelines for risk evaluation of infectious disease, examples of conditions requiring assessment and questionnaires designed to elicit relevant information about a donor's medical history and general health.

The paper has been updated in 2014.

Out of date

Donor work-up and transport of bone marrow--recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups of the World Marrow Donor Association (WMDA).One of the first WMDA publications describing donor work-up.Out of date

















Page Tree
root@home
excerpttrue